Literature DB >> 19917533

Telomerase deficiency and cancer susceptibility syndromes.

Rosario Perona1, Rosario Machado-Pinilla, Cristina Manguan, Jaime Carrillo.   

Abstract

Telomeres from most eukaryotes are composed of repeats of guanine-rich sequences whose main function is to preserve the end of the chromosomes. Telomeres are synthesised by a reverse transcriptase enzyme, telomerase (TERT), which forms part of a ribonucleoprotein complex containing also a RNA template molecule (TERC) and dyskerin. Exhaustion of telomeres during cell divisions triggers a DNA damage response that induces a senescence phenotype. The DNA damage machinery plays an essential role in maintaining the integrity of the genome and also detecting telomere shortening. However in some syndromes that involved mutations either in the telomerase complex genes or those involved in maintaining DNA secondary structure, such as the recQ helicase WRN, a higher frequency in the development of different types of malignancies is observed. We here describe the biology of some of these diseases, together with the molecular modifications in the telomerase complex genes and the impact of these alterations on the development of particular types of cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917533     DOI: 10.1007/s12094-009-0432-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  25 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 2.  Dyskeratosis congenita.

Authors:  Tom Vulliamy; Inderjeet Dokal
Journal:  Semin Hematol       Date:  2006-07       Impact factor: 3.851

3.  Dysfunctional telomeres and dyskeratosis congenita.

Authors:  Monica Bessler; Hong-Yan Du; Baiwei Gu; Philip J Mason
Journal:  Haematologica       Date:  2007-08       Impact factor: 9.941

Review 4.  Dyskerin, telomerase and the DNA damage response.

Authors:  BaiWei Gu; Monica Bessler; Philip J Mason
Journal:  Cell Cycle       Date:  2009-01-24       Impact factor: 4.534

5.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

Authors:  N S Heiss; S W Knight; T J Vulliamy; S M Klauck; S Wiemann; P J Mason; A Poustka; I Dokal
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

Review 6.  Telomere length, stem cells and aging.

Authors:  Maria A Blasco
Journal:  Nat Chem Biol       Date:  2007-10       Impact factor: 15.040

7.  The role of recombination in telomere length maintenance.

Authors:  Nicola J Royle; Aarón Méndez-Bermúdez; Athanasia Gravani; Clara Novo; Jenny Foxon; Jonathan Williams; Victoria Cotton; Alberto Hidalgo
Journal:  Biochem Soc Trans       Date:  2009-06       Impact factor: 5.407

Review 8.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

9.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.

Authors:  Tom Vulliamy; Richard Beswick; Michael Kirwan; Anna Marrone; Martin Digweed; Amanda Walne; Inderjeet Dokal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

10.  Telomeric D-loops containing 8-oxo-2'-deoxyguanosine are preferred substrates for Werner and Bloom syndrome helicases and are bound by POT1.

Authors:  Avik Ghosh; Marie L Rossi; Jason Aulds; Deborah Croteau; Vilhelm A Bohr
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

View more
  7 in total

1.  Aging genetics and aging.

Authors:  Sandra Rodríguez-Rodero; Juan Luis Fernández-Morera; Edelmiro Menéndez-Torre; Vincenzo Calvanese; Agustín F Fernández; Mario F Fraga
Journal:  Aging Dis       Date:  2011-04-28       Impact factor: 6.745

2.  PCB153 reduces telomerase activity and telomere length in immortalized human skin keratinocytes (HaCaT) but not in human foreskin keratinocytes (NFK).

Authors:  P K Senthilkumar; L W Robertson; G Ludewig
Journal:  Toxicol Appl Pharmacol       Date:  2011-12-22       Impact factor: 4.219

Review 3.  Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.

Authors:  Simone Mocellin; Daunia Verdi; Karen A Pooley; Maria T Landi; Kathleen M Egan; Duncan M Baird; Jennifer Prescott; Immaculata De Vivo; Donato Nitti
Journal:  J Natl Cancer Inst       Date:  2012-04-20       Impact factor: 13.506

Review 4.  Healthy aging and disease: role for telomere biology?

Authors:  Haidong Zhu; Matthew Belcher; Pim van der Harst
Journal:  Clin Sci (Lond)       Date:  2011-05       Impact factor: 6.124

5.  TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres.

Authors:  A M Jones; A D Beggs; L Carvajal-Carmona; S Farrington; A Tenesa; M Walker; K Howarth; S Ballereau; S V Hodgson; A Zauber; M Bertagnolli; R Midgley; H Campbell; D Kerr; M G Dunlop; I P M Tomlinson
Journal:  Gut       Date:  2011-06-27       Impact factor: 23.059

6.  Identification of TNFAIP6 as a hub gene associated with the progression of glioblastoma by weighted gene co-expression network analysis.

Authors:  Dongdong Lin; Wei Li; Nu Zhang; Ming Cai
Journal:  IET Syst Biol       Date:  2022-06-29       Impact factor: 1.468

7.  RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC.

Authors:  Mrinmoyee Majumder; Reniqua House; Nallasivam Palanisamy; Shuo Qie; Terrence A Day; David Neskey; J Alan Diehl; Viswanathan Palanisamy
Journal:  PLoS Genet       Date:  2016-09-08       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.